In a perspective, Northwestern Engineering’s Chad Mirkin and Milan Mrksich argue that structural precision drives therapeutic ...

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers ...

Coya Therapeutics sees success in early COYA-302 FTD trial, aims for Phase 2b in H2 2025 and ALS filing in Q2 2025. Read why ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities.

Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.

Merck licenses Cyprumed's oral drug delivery platform in $493M deal to develop oral peptide formulations, potentially for GLP-1 drugs.

Cancer drugs that inhibit CDK7 rapidly shut down pathways responsible for cell proliferation within minutes. For organs to ...

Karishma Shanghvi is playing a key role in the corporate social responsibility (CSR) projects at Sun Pharma, one of India’s biggest pharmaceutical companies with a market value of over Rs.

Join Judy Ashworth as she discusses her role in advancing regenerative treatments within the biotech industry and her career ...

(File photo by Arnd Wiegmann/Reuters) Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United States, including a research hub in ...

Ringaskiddy (Ireland) (AFP) – Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's ...